Immunepeptides Limited
06681631
Some Concerns
- No accounts filed in last 18 months (-5)
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
30/09/2024
micro entity
Next accounts due
30/06/2026
Confirmation statement
Last: 27/08/2025
Due 10/09/2026
Industry
Officers
director · Since 15/09/2008
DIRECTOR
BRITISH · UNITED KINGDOM · Age 81
Also on 8 other boards
secretary · Since 18/11/2011
Persons with Significant Control
Professor Arthur Randell Bradwell
British · United Kingdom · Age 81
24, Serpentine Road, Birmingham, B17 9RE
Notified 06/04/2016
CompanyRankvs 1368+ SIC 72110 peers54
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/09/2024
Net Worth
£62k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£62k
Working capital
Current Assets
£2k
Current Liabilities
£64k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 0.04 | +£120 |
| 2023 | 0.04 | +£240 |
| 2022 | 0.04 | +£480 |
| 2021 | 0.05 | +£480 |
| 2020 | 0.06 | +£0 |
| 2019 | 0.06 | +£420 |
| 2018 | 0.07 | — |
Derived from filed accounts. Not audited figures.